I am a PhD student investigating the role of myeloid cells in responses to radiotherapy and immunotherapy in muscle-invasive bladder cancer. I will be utilising multiplexed immunofluorescence and transcriptomic techniques on clinical trial samples to gain a wider understanding of the myeloid population interactions within the tumour microenvironment.

I am a Clinical Oncology registrar undertaking an MD focussing on improved biomarker-driven risk stratification and prediction of treatment response in Prostate Cancer. I use digital pathology analysis of diagnostic core biopsy H&E slides from large retrospective studies, along with techniques such as multiplex immunofluorescence and TCR sequencing to evaluate the Prostate Cancer tumour and immune landscape, and longitudinal response to radiotherapy.

From enjoying Cancer and Immunology modules in my Imperial College BSc, my Cancer Biology MRes included in vitro CRAF-RAS investigations at the Crick and some unexpected COVID work. My ICR PhD investigated bladder tumour, blood and urine clinical trial samples with genomics, transcriptomics, mIF and flow cytometry, which I’m continuing as a postdoc.

I am a postdoctoral training fellow studying the role of cancer-associated fibroblasts in muscle-invasive bladder cancer. I use multiplex immunofluorescence and digital pathology analysis to quantify the cellular composition and spatial arrangement of cancer-associated fibroblasts in the retrospective clinical trial samples.

Shuang joined Professor Berrington’s research team in November 2025 as a PhD student. She completed a Master of Public Health (MPH) at Imperial College London in September 2025, specialising in environmental and cancer epidemiology. Her research examines how environmental exposures and cancer treatments influence cancer risk and survivorship. She is currently using population-based data to investigate the late effects of paediatric cancer treatment and to help inform guidelines for surveillance and screening strategies for survivors.